Application of Biosheets As Right Ventricular Outflow Tract Repair Materials in a Rat Model

Overview

Journal Front Vet Sci

Specialty Veterinary Medicine

Date 2022 Apr 25

PMID 35464349

Authors

Takeshi Mizuno

Ryosuke Iwai

Takeshi Moriwaki

Yasuhide Nakayama

Affiliations

Soon will be listed here.

Abstract

Purposes: We report the experimental use of completely autologous biomaterials (Biosheets) made by "in-body tissue architecture" that could resolve problems in artificial materials and autologous pericardium. Here, Biosheets were implanted into full-thickness right ventricular outflow tract defects in a rat model. Their feasibility as a reparative material for cardiac defects was evaluated.

Methods: As the evaluation of mechanical properties of the biosheets, the elastic moduli of the biosheets and RVOT-free walls of rats were examined using a tensile tester. Biosheets and expanded polytetrafluoroethylene sheet were used to repair transmural defects surgically created in the right ventricular outflow tracts of adult rat hearts ( = 9, each patch group). At 4 and 12 weeks after the operation, the hearts were resected and histologically examined.

Results: The strength and elastic moduli of the biosheets were 421.3 ± 140.7 g and 2919 ± 728.9 kPa, respectively, which were significantly higher than those of the native RVOT-free walls (93.5 ± 26.2 g and 778.6 ± 137.7 kPa, respectively; < 0.005 and < 0.001, respectively). All patches were successfully implanted into the right ventricular outflow tract-free wall of rats. Dense fibrous adhesions to the sternum on the epicardial surface were also observed in 7 of 9 rats with ePTFE grafts, whereas 2 of 9 rats with biosheets. Histologically, the vascular-constructing cells were infiltrated into Biosheets. The luminal surfaces were completely endothelialized in all groups at each time point. There was also no accumulation of inflammatory cells.

Conclusions: Biosheets can be formed easily and have sufficient strength and good biocompatibility as a patch for right ventricular outflow tract repair in rats. Therefore, Biosheet may be a suitable material for reconstructive surgery of the right ventricular outflow tract.

Citing Articles

Development of a skeletal muscle sheet with direct reprogramming-induced myoblasts on a nanogel-cross-linked porous freeze-dried gel scaffold in a mouse gastroschisis model.

Nagano S, Fumino S, Kishida T, Wakao J, Hirohata Y, Takayama S Pediatr Surg Int. 2024; 40(1):241.

PMID: 39183231 DOI: 10.1007/s00383-024-05811-z.

Successful tracheal regeneration using biofabricated autologous analogues without artificial supports.

Hiwatashi S, Iwai R, Nakayama Y, Moriwaki T, Okuyama H Sci Rep. 2022; 12(1):20279.

PMID: 36434016 PMC: 9700768. DOI: 10.1038/s41598-022-24798-y.

References

Nakayama Y, Oshima N, Tatsumi E, Ichii O, Nishimura T . iBTA-induced bovine Biosheet for repair of abdominal wall defects in a beagle model: proof of concept. Hernia. 2018; 22(6):1033-1039. DOI: 10.1007/s10029-018-1799-8. View

Funayama M, Takewa Y, Oie T, Matsui Y, Tatsumi E, Nakayama Y . In situ observation and enhancement of leaflet tissue formation in bioprosthetic "biovalve". J Artif Organs. 2014; 18(1):40-7. DOI: 10.1007/s10047-014-0793-x. View

Iwai R, Tsujinaka T, Nakayama Y . Preparation of Biotubes with vascular cells component by in vivo incubation using adipose-derived stromal cell-exuding multi-microporous molds. J Artif Organs. 2015; 18(4):322-9. DOI: 10.1007/s10047-015-0848-7. View

Hayashida K, Kanda K, Oie T, Okamoto Y, Ishibashi-Ueda H, Onoyama M . Architecture of an in vivo-tissue engineered autologous conduit "Biovalve". J Biomed Mater Res B Appl Biomater. 2007; 86(1):1-8. DOI: 10.1002/jbm.b.30981. View

Nakayama Y, Ishibashi-Ueda H, Takamizawa K . In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube). Cell Transplant. 2004; 13(4):439-49. DOI: 10.3727/000000004783983828. View

Mizuno T, Takewa Y, Sumikura H, Ohnuma K, Moriwaki T, Yamanami M . Preparation of an autologous heart valve with a stent (stent-biovalve) using the stent eversion method. J Biomed Mater Res B Appl Biomater. 2013; 102(5):1038-45. DOI: 10.1002/jbm.b.33086. View

Lloyd-Jones D, Adams R, Carnethon M, de Simone G, Ferguson T, Flegal K . Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 119(3):e21-181. DOI: 10.1161/CIRCULATIONAHA.108.191261. View

Takiyama N, Mizuno T, Iwai R, Uechi M, Nakayama Y . In-body tissue-engineered collagenous connective tissue membranes (BIOSHEETs) for potential corneal stromal substitution. J Tissue Eng Regen Med. 2014; 10(10):E518-E526. DOI: 10.1002/term.1859. View

Furukoshi M, Tatsumi E, Nakayama Y . Application of in-body tissue architecture-induced Biotube vascular grafts for vascular access: Proof of concept in a beagle dog model. J Vasc Access. 2019; 21(3):314-321. DOI: 10.1177/1129729819874318. View

10.

Takewa Y, Sumikura H, Kishimoto S, Naito N, Iizuka K, Akiyama D . Implanted In-Body Tissue-Engineered Heart Valve Can Adapt the Histological Structure to the Environment. ASAIO J. 2018; 64(3):395-405. DOI: 10.1097/MAT.0000000000000769. View

11.

Metzner A, Stock U, Iino K, Fischer G, Huemme T, Boldt J . Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents. Cardiovasc Res. 2010; 88(3):453-61. DOI: 10.1093/cvr/cvq212. View

12.

Nakayama Y, Kaneko Y, Okumura N, Terazawa T . Initial 3-year results of first human use of an in-body tissue-engineered autologous "Biotube" vascular graft for hemodialysis. J Vasc Access. 2019; 21(1):110-115. DOI: 10.1177/1129729819852550. View

13.

Brown J, Ruzmetov M, Vijay P, Rodefeld M, Turrentine M . Right ventricular outflow tract reconstruction with a polytetrafluoroethylene monocusp valve: a twelve-year experience. J Thorac Cardiovasc Surg. 2007; 133(5):1336-43. DOI: 10.1016/j.jtcvs.2006.12.045. View

14.

Nakayama Y, Kaneko Y, Takewa Y, Okumura N . Mechanical properties of human autologous tubular connective tissues (human biotubes) obtained from patients undergoing peritoneal dialysis. J Biomed Mater Res B Appl Biomater. 2015; 104(7):1431-7. DOI: 10.1002/jbm.b.33495. View

15.

Terazawa T, Nishimura T, Mitani T, Ichii O, Ikeda T, Kosenda K . Wall thickness control in biotubes prepared using type-C mold. J Artif Organs. 2018; 21(3):387-391. DOI: 10.1007/s10047-018-1035-4. View

16.

Watanabe T, Kanda K, Yamanami M, Ishibashi-Ueda H, Yaku H, Nakayama Y . Long-term animal implantation study of biotube-autologous small-caliber vascular graft fabricated by in-body tissue architecture. J Biomed Mater Res B Appl Biomater. 2011; 98(1):120-6. DOI: 10.1002/jbm.b.31841. View

17.

Funayama M, Furukoshi M, Moriwaki T, Nakayama Y . Development of an in vivo tissue-engineered valved conduit (type S biovalve) using a slitted mold. J Artif Organs. 2015; 18(4):382-6. DOI: 10.1007/s10047-015-0856-7. View

18.

Nakayama Y, Furukoshi M, Terazawa T, Iwai R . Development of long in vivo tissue-engineered "Biotube" vascular grafts. Biomaterials. 2018; 185:232-239. DOI: 10.1016/j.biomaterials.2018.09.032. View

19.

Nakayama Y, Takewa Y, Sumikura H, Yamanami M, Matsui Y, Oie T . In-body tissue-engineered aortic valve (Biovalve type VII) architecture based on 3D printer molding. J Biomed Mater Res B Appl Biomater. 2014; 103(1):1-11. DOI: 10.1002/jbm.b.33186. View

20.

Nakayama Y, Furukoshi M, Tatsumi E . Shape memory of in-body tissue-engineered Biotube® vascular grafts and the preliminary evaluation in animal implantation experiments. J Cardiovasc Surg (Torino). 2019; 61(2):208-213. DOI: 10.23736/S0021-9509.19.10594-0. View